BioCentury | May 8, 2017
Distillery Therapeutics

Endocrine / Metabolic

...a cholic acid-based agonist of GPBAR1, in preclinical testing to treat Type II diabetes. Sensor Pharmaceuticals Inc....
BioCentury | Nov 6, 2014
Targets & Mechanisms

Greasing insulin

...to the regulation of GPR120 was not known," said Jim Hauske, president and founder of Sensor Pharmaceuticals Inc....
...London, U.K. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Metabolon Inc. , Durham, N.C. Sensor Pharmaceuticals Inc....
BioCentury | Aug 12, 2013
Emerging Company Profile

Sensor: Combination gut shot

...New York, N.Y. Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. Sensor Pharmaceuticals Inc. , San Diego, Calif. Sidebars Sensor Pharmaceuticals Inc....
Items per page:
1 - 3 of 3
BioCentury | May 8, 2017
Distillery Therapeutics

Endocrine / Metabolic

...a cholic acid-based agonist of GPBAR1, in preclinical testing to treat Type II diabetes. Sensor Pharmaceuticals Inc....
BioCentury | Nov 6, 2014
Targets & Mechanisms

Greasing insulin

...to the regulation of GPR120 was not known," said Jim Hauske, president and founder of Sensor Pharmaceuticals Inc....
...London, U.K. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Metabolon Inc. , Durham, N.C. Sensor Pharmaceuticals Inc....
BioCentury | Aug 12, 2013
Emerging Company Profile

Sensor: Combination gut shot

...New York, N.Y. Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), Cambridge, Mass. Sensor Pharmaceuticals Inc. , San Diego, Calif. Sidebars Sensor Pharmaceuticals Inc....
Items per page:
1 - 3 of 3